11
Kwang H Liu, Sorin L Negru, Fu Yuan Shih, George Hsieh: Boost-buck cascade converter for pulsating loads. Arques Technology, Anthony B Diependbrock III, Dechert, September 28, 2004: US06798177 (85 worldwide citation)

A power converter including a first stage, a reservoir capacitor and a second stage. The first stage converts the voltage of a primary energy source, such as a battery, to a voltage on the reservoir capacitor, which stores a large amount of energy in the form of a voltage substantially larger than t ...


12
Majken Westergaard, Charlotte A Thrue, Frank W Rasmussen, Henrik F Hansen: Potent LNA oligonucleotides for the inhibition of HIF-1A expression. Santaris Pharma, Dechert, September 15, 2009: US07589190 (79 worldwide citation)

The present disclosure relates to an LNA oligonucleotide consisting of a sequence selected from the group consisting of 5′-(Tx)GxGxcsasasgscsastscscsTxGxT-3′ and 5′-(Gx)TxTxascstsgscscststscsTxTxA-3′, wherein capital letters designate a beta-D-oxy-LNA nucleotide analogue, small letters designate a 2 ...


13
Li Lan H Chen, William R Pfister, Donald W Renn, Thitiwan Buranachokpaisan, James Osborne, Hock Seng Tan, Li Tao: Compositions and methods for mucosal delivery. Lavipharm Laboratories, Thomas S Deibert, Dechert, April 22, 2003: US06552024 (76 worldwide citation)

Mucosal surface-coat-forming film dosage units containing a water-soluble hydrocolloid, an effective dose of an active agent and a mucosal adhesion enhancer; wherein the active agent is encapsulated within a polymer which is chemically or physically distinct from the hydocolloid; wherein the mucosal ...


14
Jens Bo Rode Hansen, Charlotte Albaek Thrue, Majken Westergaard, Kamille Dumong Petersen, Margit Wissenbach: Oligomeric compounds for the modulation of survivin expression. Santaris Pharma, Dechert, June 22, 2010: US07741309 (73 worldwide citation)

Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivi ...


15
Charlotte Albæk Thrue, Anja Mølhart Høg, Paul E G Kristjansen: Oligomeric compounds for the modulation HIF-1α expression. Santaris Pharma, Dechert, June 15, 2010: US07737264 (73 worldwide citation)

Oligonucleotides directed against the hypoxia-inducible factor-1α (HIF-1α) gene are provided for modulating the expression of HIF-1α. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the HIF-1α. Methods of using these compounds f ...


16
Bo Hansen, Charlotte Albæk Thrue, Majken Westergaard, Kamille Dumong Petersen, Margit Wissenbach: Oligomeric compounds for the modulation of survivin expression. Santaris Pharma, Dechert, May 11, 2010: US07713738 (72 worldwide citation)

Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivi ...


17
Dong Donald Nguyen: Method and apparatus for reducing membrane fouling. Union Camp Corporation, Dechert Price & Rhoads, March 30, 1999: US05888401 (72 worldwide citation)

The present invention is directed, among other things, to methods for reducing fouling of a separation membrane having a concentrate side subject to a concentrate pressure (Pc) and a permeate side subject to permeate pressure (Pp), comprising raising an initial permeate pressure (Pp.sub.0) to an inc ...


18
Lyle W Spruce, Albert C Gyorkos, John C Cheronis, Val S Goodfellow, Axel H Leimer, John M Young, James Ivan Gerrity: Cysteine protease inhibitors. Cortech, Dechert Price & Rhoads, December 21, 1999: US06004933 (61 worldwide citation)

The present invention relates to cysteine protease inhibitors of the general formula (I): ##STR1## wherein Z is a cysteine protease binding moiety; X and Y are S, O or optionally substituted N; and R.sub.1 is optionally substituted alkyl or aryl.


19
Michael Buss: Child-resistant product package. Fisher Clinical Services, Daniel S Goldberg, Dechert, February 26, 2002: US06349831 (54 worldwide citation)

The invention relates to child-resistant package having a shell with a first locking part and a tray having blister card coupled to a tether having a second locking part. In a closed position the first locking part engages the second locking part to limit the movement of the tray relative to the she ...


20
Carlos Martinez Celis Cantu, Mario Martinez Celis Greenham: Convertible seating and sleeping accommodations for aircraft. Carlos Martinez Celis Cantu, Mario Martinez Celis Greenham, David Martinez Celis Greenham, Miguel Avalos Sartorio, Carlos Avalos Sartorio, Dechert Price and Rhoads, May 2, 2000: US06056239 (51 worldwide citation)

This invention relates to aircraft passenger accommodations which are easily and individually convertible from a sitting position to a reclining position. The accommodations provide privacy and security in single or double occupancy configurations.